GE Vernova misses earnings, revenue estimates in Q4; stock down
GE Vernova (NYSE:GEV) saw its shares slide more than 4% in premarket trading Wednesday after the company's fourth-quarter ...
Johnson & Johnson posts Q4 beat as drug sales offset MedTech weakness
Johnson & Johnson (NYSE:JNJ) traded flat in the premarket on Wednesday after the pharma giant exceeded Street forecasts for Q4 2024, mainly due to its Innovative Medicine unit, while its MedTech ...